On this page:OverviewPublicationsResearchersKey papersJournalsOpen accessInstitutions
ScholarIQanswers from OpenAlex

Psychedelics and Drug Studies

TopicLeading institutions, researchers & key papers

Psychedelics and Drug Studies is a topic indexed in ScholarIQ from OpenAlex.

What is known about Psychedelics and Drug Studies?

ScholarIQrecord summary

This cluster of papers explores the therapeutic potential of psychedelic therapy, particularly focusing on the use of substances like psilocybin and MDMA for the treatment of depression, anxiety, and substance dependence. The research delves into the neurobiology, serotonin receptors, and brain function underlying the effects of these psychedelics, as well as their ability to induce mystical experiences and promote long-lasting positive changes in psychological functioning.

How many works does Psychedelics and Drug Studies have?

ScholarIQindexed works

Psychedelics and Drug Studies has 100 works in the ScholarIQ index. The count is the OpenAlex total, not the number of papers listed on this page.

What is the OpenAlex record for Psychedelics and Drug Studies?

ScholarIQopenalex

The OpenAlex for Psychedelics and Drug Studies is on the source record.

What are the most-cited papers on Psychedelics and Drug Studies?

ScholarIQmost cited works
Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial
Roland R. Griffiths, Matthew W. Johnson, Michael A. Carducci, Annie Umbricht, William A. Richards, Brian D. Richards, Mary P Cosimano, Margaret A. Klinedinst
Journal of Psychopharmacology. 20162,197 CitationsOPEN ACCESS
Neural correlates of the psychedelic state as determined by fMRI studies with psilocybin
Robin Carhart‐Harris, David Erritzøe, Tom A. Williams, James Stone, Laurence Reed, Alessandro Colasanti, Robin J. Tyacke, Robert Leech, Andrea L. Malizia, Kevin Murphy, Peter Hobden, John Evans, Amanda Feilding, Richard G. Wise, David Nutt
Proceedings of the National Academy of Sciences. 20121,197 CitationsOPEN ACCESS
Neural correlates of the LSD experience revealed by multimodal neuroimaging
Robin Carhart‐Harris, Suresh Muthukumaraswamy, Leor Roseman, Mendel Kaelen, Wouter Droog, Kevin Murphy, Enzo Tagliazucchi, Eduardo Ekman Schenberg, Timothy Nest, Csaba Orbán, Robert Leech, Luke T. Williams, Tom A. Williams, Mark Bolstridge, Ben Sessa, John McGonigle, Martin I. Sereno, David E. Nichols, Peter J. Hellyer, Peter Hobden, John Evans, Krish D. Singh, Richard G. Wise, H. Valerie Curran, Amanda Feilding, David Nutt
Proceedings of the National Academy of Sciences. 2016889 CitationsOPEN ACCESS
Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial
Fernanda Palhano-Fontes, Dayanna Barreto, Heloisa Onias, Kátia C. Andrade, Morgana Menezes Novaes, Jéssica Andrade Pessoa, Sérgio Mota‐Rolim, Flávia de Lima Osório, Rafael Faria Sanches, Rafael G. dos Santos, Luís Fernando Tófoli, Gabriela de Oliveira Silveira, Maurı́cio Yonamine, Jordi Riba, Francisco R. Santos, Antonio A Silva-Junior, João Carlos Alchieri, Nicole Leite Galvão‐Coelho, Bruno Lobão‐Soares, Jaime E. C. Hallak, Emerson Arcoverde, João Paulo Maia‐de‐Oliveira, Dráulio Barros de Araújo
Psychological Medicine. 2018830 CitationsOPEN ACCESS
Lysergic acid diethylamide (LSD) for alcoholism: meta-analysis of randomized controlled trials
Teri Suzanne Krebs, Pål-Ørjan Johansen
Journal of Psychopharmacology. 2012583 Citations

Where is Psychedelics and Drug Studies research published, and who funds it?

ScholarIQvenues & funding sources

TOP FUNDERS

National Science Foundation—
NIH—
Wellcome Trust—
European Research Council—
Funder breakdown is a member featureSign up free to unlock

How much of the research on Psychedelics and Drug Studies is open access?

ScholarIQopen access share
80%OPEN ACCESS
Gold
33%
Green
13%
Hybrid
20%
Bronze
13%
Closed
20%

Related on ScholarIQ

470M+ articles · 14-day free trial